Frances K Heller - Net Worth and Insider Trading
Frances K Heller Net Worth
The estimated net worth of Frances K Heller is at least $44,202 dollars as of 2024-09-20. Frances K Heller is the EVP, Business Development of Exelixis Inc and owns about 1,500 shares of Exelixis Inc (EXEL) stock worth over $40,245. Frances K Heller is also the Director of Zafgen Inc and owns about 3,997 shares of Zafgen Inc (ZFGN) stock worth over $3,957. Details can be seen in Frances K Heller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frances K Heller has not made any transactions after 2017-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frances K Heller
Frances K Heller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frances K Heller owns 4 companies in total, including Larimar Therapeutics Inc (LRMR) , Bristol-Myers Squibb Co (BMY) , and Exelixis Inc (EXEL) among others .
Click here to see the complete history of Frances K Heller’s form 4 insider trades.
Insider Ownership Summary of Frances K Heller
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LRMR | Larimar Therapeutics Inc | 2015-07-13 | director |
BMY | Bristol-Myers Squibb Co | 2013-10-01 | SVP & Business Development |
EXEL | Exelixis Inc | 2009-11-02 | EVP & Business Development |
2021-09-30 | director |
Frances K Heller Latest Holdings Summary
Frances K Heller currently owns a total of 2 stocks. Among these stocks, Frances K Heller owns 1,500 shares of Exelixis Inc (EXEL) as of November 2, 2009, with a value of $40,245 and a weighting of 91.05%. Frances K Heller also owns 3,997 shares of Zafgen Inc (ZFGN) as of October 13, 2017, with a value of $3,957 and a weighting of 8.95%.
Latest Holdings of Frances K Heller
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EXEL | Exelixis Inc | 2009-11-02 | 1,500 | 26.83 | 40,245 |
ZFGN | Zafgen Inc | 2017-10-13 | 3,997 | 0.99 | 3,957 |
Holding Weightings of Frances K Heller
Frances K Heller Form 4 Trading Tracker
According to the SEC Form 4 filings, Frances K Heller has made a total of 0 transactions in Exelixis Inc (EXEL) over the past 5 years. The most-recent trade in Exelixis Inc is the sale of 2,529 shares on November 2, 2009, which brought Frances K Heller around $15,655.
According to the SEC Form 4 filings, Frances K Heller has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the acquisition of 833 shares on October 13, 2017, which cost Frances K Heller around $39,000.
Insider Trading History of Frances K Heller
- 1
Frances K Heller Trading Performance
GuruFocus tracks the stock performance after each of Frances K Heller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frances K Heller is 26.88%. GuruFocus also compares Frances K Heller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frances K Heller within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frances K Heller's insider trading performs compared to the benchmark.
Performance of Frances K Heller
Frances K Heller Ownership Network
Frances K Heller Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Frances K Heller is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Frances K Heller made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Carole Ben-maimon .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Frances K Heller Mailing Address
Above is the net worth, insider trading, and ownership report for Frances K Heller. You might contact Frances K Heller via mailing address: 249 E. Grand Avenue, S. San Francisco Ca 94083.